PD-L1-IN-5

PD-1/PD-L1

Immunology/Inflammation|||Cell Cycle/Checkpoint|||Apoptosis

PD-L1-IN-5 (X22) is an orally active PD-L1 inhibitor with an IC50 of 785.6 nM, demonstrating antitumor activity in vivo.

Cool pack

-20°C